San Francisco—Aspirin can have a significant positive effect on prostate cancer, according to results from the large, observational Physicians’ Health Study.
“Our study demonstrates that regular aspirin intake may inhibit lethal prostate cancer, probably by preventing cancer progression,” said lead study author Christopher Allard, MD, a urologic oncology fellow at Brigham and Women’s Hospital and Harvard Medical School, both in Boston, who presented the